组织学,超结构学和单细胞分析显示,胆囊炎炎的免疫媒介重塑
Dmytro Vlasenko1, Andrea Maccagno2, Adriano Sanna3
1Department of General, Visceral and Transplantation Surgery, University Hospital Augsburg, Augsburg, Germany.
Cell and tissue research
|March 4, 2026
概括
胆囊炎症涉及不同的细胞程序. 急性胆囊炎表现为中性粒细胞透,而慢性胆囊病表现为纤维化和巨细胞-B细胞-纤维细胞网络,揭示了特定疾病的免疫反应.
科学领域:
- 胃肠道学和免疫学
- 细胞和分子生物学 细胞和分子生物学
- 病理学 病理学 病理学
背景情况:
- 胆囊炎症呈现为急性损伤或慢性重塑.
- 了解细胞和结构差异对于向治疗至关重要.
研究的目的:
- 定义急性胆囊炎和慢性胆病中不同的细胞和结构程序.
- 在胆囊炎症中将表皮质,免疫和脑膜变化联系起来.
主要方法:
- 组织病理学,免疫组织化学和传输电子显微镜.
- 细胞因子表达分析和单细胞RNA测序.
- 分析了41名患者的组织和血液样本.
主要成果:
- 急性胆囊炎:上皮损伤,中性粒细胞/巨细胞透,系统性炎症升高.
- 慢性胆病:纤维化,腺体重塑,免疫细胞减少,显著的巨细胞-B细胞-纤维细胞网络.
- 单细胞RNA测序确定了12个具有对比配置的免疫和 stromal 种群.
结论:
- 显著的免疫风暴程序是急性和慢性胆囊炎症的特征.
- 这些发现为了解疾病特异性机制提供了细胞框架.
- 这项研究强调了适应性重塑,而不是简单的时间进展.
相关概念视频
Chronic Bowel Disorders: Introduction
861
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
861
Gallbladder
2.7K
The gallbladder is a small, pear-shaped organ that plays a crucial role in our digestive system. Measuring about 10 cm in length, it is comparable in size to a kiwi fruit and is located in a hollow area on the lower surface of the liver. The gallbladder's primary function is to store and concentrate bile, a fluid produced by the liver that aids in digestion.
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins...
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins...
2.7K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
616
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
616
Inflammatory Bowel Disease IV: Pharmacological Management
873
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
873
Gastritis-II: Pathophysiology
1.5K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.5K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
670
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
670


